News
21h
Zacks Investment Research on MSNAmgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...
BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...
Regeneron Pharmaceuticals yesterday said it will buy genetic testing company 23andMe out of bankruptcy for US$256 million, a ...
On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2025 investor letter. A copy ...
Avant Technologies, Inc. ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using ...
Regeneron Pharmaceuticals said it will buy genetic testing company 23andMe out of bankruptcy for $256 million.
Not since DDT was introduced to U.S. agriculture to kill insects after World War Two has a farm chemical been as important to ...
Despite recent stock corrections, Piramal Pharma has shown remarkable resilience, tripling investor wealth since 2023-24.
The global Distribution Automation Market is anticipated to grow from estimated USD 20.56 billion in 2025 to USD 40.40 billion by 2030, at a CAGR of 14.5% during the forecast period. The Distribution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results